GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (CHIX:CAMXs) » Definitions » Other Long Term Assets

Camurus AB (CHIX:CAMXS) Other Long Term Assets : kr87 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Other Long Term Assets?

Camurus AB's other long-term assets for the quarter that ended in Mar. 2025 was kr87 Mil.

Camurus AB's quarterly other long-term assets declined from Sep. 2024 (kr169 Mil) to Dec. 2024 (kr127 Mil) but then stayed the same from Dec. 2024 (kr127 Mil) to Mar. 2025 (kr87 Mil).

Camurus AB's annual other long-term assets declined from Dec. 2022 (kr332 Mil) to Dec. 2023 (kr221 Mil) and declined from Dec. 2023 (kr221 Mil) to Dec. 2024 (kr127 Mil).

Camurus AB Other Long Term Assets Historical Data

The historical data trend for Camurus AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Other Long Term Assets Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 305.12 334.15 331.67 221.32 127.44

Camurus AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 218.46 196.49 168.56 127.44 87.19

Camurus AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Camurus AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (CHIX:CAMXs) » Definitions » Other Long Term Assets
Comparable Companies
OSTO:BIOA B OSTO:FLERIE OSTO:BINV OSTO:VICO OSTO:GENO OSTO:HNSA OSTO:DMYD B OSTO:SANION OSTO:XSPRAY OSTO:EGTX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
CAMRF:USA CAMX:Sweden 0RD1:UK 7CA:Germany
Address
Ideon Science Park, Lund, SWE, SE-223 70
Website
https://www.camurus.com
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines